• DOI:10.1177/1740774515625964
Corpus ID: 24308679

Key cost drivers of pharmaceutical clinical trials in the United States

@article{Sertkaya2016KeyCD,
  title={Key cost drivers of pharmaceutical clinical trials in the United States},
  author={A. Sertkaya and Hui-Hsing Wong and Amber Jessup and Trinidad Beleche},
  journal={Clinical Trials},
  year={2016},
  volume={13},
  pages={117 - 126}
}

A. Sertkaya, Hui-Hsing Wong, +1 author Trinidad Beleche

Published 2016

Medicine

Clinical Trials

Background: The increasing cost of clinical research has significant implications for public health, as it affects drug companies’ willingness to undertake clinical trials, which in turn limits patient access to novel treatments. [...] Key Method We evaluated per-study costs across therapeutic areas by aggregating detailed (per patient and per site) cost information. We also compared average expenditures on cost drivers with the use of weighted mean and standard deviation statistics. Results: Therapeutic area…Expand Abstract

View on SAGE

journals.sagepub.com

Save to Library

Create Alert

Cite

Launch Research Feed